You searched for London - Page 22 of 35

In Depth 24 Jul 2023

Sarcoma research: is a breakthrough in sight?

…will enroll 44 patients with sarcoma. As biotechs step up their therapeutic research, like London-based clinical-stage company Avacta, which received orphan drug status for its chemotherapy drug doxorubicin AVA6000 for…

July 24, 2023 - 7 minutesmins - By Roohi Mariam Peter

cancer vaccine virus ervaxx cell therapy

News and Trends 17 Aug 2020

CureVac Continues Covid-19 Vaccine Funding Frenzy with €180M IPO

…CureVac and BioNTech are the biggest fundraisers of the mRNA Covid-19 vaccine race in Europe, several other groups can’t be overlooked. For example, the UK institution Imperial College London has…

August 17, 2020 - 3 minutesmins - By Jonathan Smith

Interview 26 Feb 2018

This Biotech Could Replace Opioids with Safe and Effective Pain Relief for Osteoarthritis

…has raised £12.4M (€14M) is testing its candidate in a Phase I trial. Westbrook left Pfizer’s R&D center in Sandwich to set up Levicept in West London. I was interested…

February 26, 2018 - 9 minutesmins - By Alex Dale

Expert Advice 25 Nov 2020

How to Weather Bad Press as a Biotech Company

…Partner at Consilium Strategic Communications, a London-based healthcare communications and investor relations company. “It’s how you deal with that news that really informs on the quality of the leadership team…

November 25, 2020 - 7 minutesmins - By Victor Kotsev

BenevolentAI Artificial Intelligence Fundraising

News and Trends 19 Apr 2018

Major $115M Fundraising Fuels AI Drug Development

…the drug discovery process. BenevelontAI, based in London, has raised an impressive $115M (€93M) to advance its use of AI in drug development. The funding, raised from new and existing…

April 19, 2018 - 2 minutesmins - By Alexander Burik

Catherine Pickering iOnctura e1575382680993

Interview 22 Jul 2019

Turning Shelved Drugs into a New Promise for Immuno-Oncology

…PhD at the Institute of Cancer Research in London, where she then worked as a manager at the tech transfer unit when it was just starting out. After an MBA…

July 22, 2019 - 5 minutesmins - By Clara Rodríguez Fernández

Best in Biotech 28 Feb 2025

Rare Disease Day: seven drugs awaiting approval in 2025

…Rett Syndrome – University Health Network AAV gene therapy for Wilson’s Disease – University College London Oligonucleotide approach to treat exon skipping diseases (eg. Batten Disease) – Boston Children’s Hospital…

February 28, 2025 - 10 minutesmins - By Roohi Mariam Peter

dna sequencing covid 19 vaccine funding european biotech investment

News and Trends 10 Jun 2021

The Top European Biotech Investment Rounds in May

…Technologies, which dominated with a €227M (£195M) private round. Oxford Nanopore’s eventual aim is to list on the London Stock Exchange later this year. Biotech investments also flooded into companies…

June 10, 2021 - 4 minutesmins - By Jonathan Smith

News and Trends 24 Mar 2017

Novartis puts the Development of two Anti-Aging Drugs in American Hands

…of PureTech, a Boston-based healthcare company listed on the London stock market. Originally an investment firm, it now has put together a drug pipeline from its biotech portfolio. Its latest…

March 24, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

gene therapy cell therapy advanced therapy 4BIO

News and Trends 9 Sep 2019

4BIO Capital Raises €45M Fund to Invest in Advanced Therapies

The London-based life sciences investor 4BIO Capital has raised €45M in the first close of a fund to nurture companies developing advanced therapies such as gene and cell therapies. This…

September 9, 2019 - 3 minutesmins - By Jonathan Smith

Best in Biotech 31 Dec 2018

European Biotech’s Biggest News of 2018

…big incoming change is that the EMA, the EU’s agency in charge of approving new therapies, will move from London to Amsterdam in March 2019. This move means losing up…

December 31, 2018 - 12 minutesmins - By Jonathan Smith

News and Trends 25 Jul 2022

Replay launches with $55M to reprogram biology by writing and delivering big DNA

…with additional participation from ARTIS Ventures and Lansdowne Partners, SALT, DeciBio Ventures, and Axial. Replay, which is based in San Diego, Cal., and London, U.K., has a portfolio of next-generation…

July 25, 2022 - 3 minutesmins - By Jim Cornall

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: London

Sarcoma research: is a breakthrough in sight?

CureVac Continues Covid-19 Vaccine Funding Frenzy with €180M IPO

This Biotech Could Replace Opioids with Safe and Effective Pain Relief for Osteoarthritis

How to Weather Bad Press as a Biotech Company

Major $115M Fundraising Fuels AI Drug Development

Turning Shelved Drugs into a New Promise for Immuno-Oncology

Rare Disease Day: seven drugs awaiting approval in 2025

The Top European Biotech Investment Rounds in May

Novartis puts the Development of two Anti-Aging Drugs in American Hands

4BIO Capital Raises €45M Fund to Invest in Advanced Therapies

European Biotech’s Biggest News of 2018

Replay launches with $55M to reprogram biology by writing and delivering big DNA

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!